Legend Biotech
LEGN
LEGN
178 hedge funds and large institutions have $4.05B invested in Legend Biotech in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 48 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $4.85B → $4.05B (-$796M)
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
23% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $23.8M
Holders
178
Holding in Top 10
7
Calls
$18.3M
Puts
$23.8M
Top Buyers
| 1 | +$112M | |
| 2 | +$65.3M | |
| 3 | +$57M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$28.9M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$28.6M |
Top Sellers
| 1 | -$134M | |
| 2 | -$42.7M | |
| 3 | -$41.2M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$34.5M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$20.6M |